Professor Han Liang speaks with Cancer Network about the ubiquitin pathway and its role in cancer research.
Guang Peng, MD, PhD spoke to Cancer Network about the recent discovery that mTORC1 can help determine cell fate after DNA damage.
The FDA authorized the first next-generation sequencing test to detect minimal residual disease in blood cancers.
A study shows gene variants of uncertain significance are frequently reclassified, necessitating amended test result reports.
A study shows TRK gene fusions in hematologic cancers may respond to larotrectinib.
Nanotechnological strategies are making preclinical strides toward more effective, less toxic, immunotherapies.
A study finds EWSR1-ETS in 42% of cases via complex, loop-like rearrangements, rather than by simple reciprocal translocations.
A study shows significant association between MTHFR C677T polymorphisms and risk of oral squamous cell carcinoma.
A study shows that receipt of radioactive iodine after reoperation may not be associated with improved outcomes.
A study shows that LKB1 deficiency in T cells increases gastrointestinal polyposis development.